Dublin, Feb. 02, 2023 (GLOBE NEWSWIRE) — “Global Liquid Biopsy Market – By Biomarker Type (CTC, ctDNA, EV, Others), Products (Assay Kits, Instruments & Devices, Services), Indications By Region “Analysis by Disease, By Country: Market Size, Insights, Competition, Covid-19 Impact and Forecast (2023-2028)” report added of ResearchAndMarkets.com Recruitment.
The global liquid biopsy market is valued at USD 2.2 billion in 2021. This is underpinned by several initiatives to raise awareness of cancer initiated by governments and global health organizations over the past decade.
The report presents an analysis of the Liquid Biopsy market for the historical period 2018-2021 and the forecast period 2023-2028.
Developing countries such as India, China, South Korea, Brazil, Turkey, Russia, and South Africa are expected to offer potential growth opportunities for the liquid biopsy market players.
This may be attributed to the high cancer incidence, high prevalence, improved medical infrastructure, increased disposable income, and increased medical tourism in these countries. Apart from the aforementioned factors, Asia-Pacific has emerged as a highly adaptable and business-friendly hub due to its less stringent regulatory and data requirements.
Assay kits are essential for detecting cancer tumor cells or tumor DNA using liquid biopsy. A liquid biopsy assay is a low-cost, minimally invasive procedure that aids in patient monitoring and screening during and after treatment.
Other key factors driving the growth of the liquid biopsy assay kits market include availability of a wide range of reagents and kits, easy access to a wide range of assays, and rising prevalence of cancer.
high adoption of advanced technologies such as NGS, increasing research studies for the discovery and development of new cancer biomarkers, presence of many pharmaceutical companies, increasing funding and investment from public and private organizations; Increasing use of biomarkers, patient stratification and the drug development process are driving growth in developed markets in North America.
This report tracks competitive developments, strategies, mergers, acquisitions, and new biomarker developments.
Main indicators
| report attribute | detail |
| page number | 260 |
| Forecast period | 2022-2028 |
| Estimated market value in 2022 (USD) | $1.75 billion |
| Projected Market Value (USD) to 2028 | $4.78 billion |
| compound annual growth rate | 18.2% |
| Target area | global |
competitive positioning
- company product positioning
- market position matrix
- Market Share Analysis of Liquid Biopsy Market
- Company Profile
Companies analyzed in the report include:
- Roche Holding AG
- Abbott Laboratories
- Illumina Inc.
- BioCultis
- Guardian Health
- Qiagen
- thermo fisher scientific
- Biocept Co., Ltd.
- Bio-Rad Laboratories
- MDx Health
Main topics:
1.First of all
1.1 Liquid Biopsy Market Overview
1.2 Scope of research
2. Abstract
2.1 Market Snapshot
2.2 Regional Insights
2.3 Market ecosystem factors
3. Survey method
3.1 Data collection process
3.2 Market Trajectory Estimation
3.3 Market Size Calculation – Top to Bottom
4 Market dynamics
4.1 Driver
4.2 Constraints
4.3 Opportunities
4.4 Analyst Recommendations
4.5 Trends
4.6 Impact analysis
5. Value chain analysis
5.1 Value Chain Analysis of Liquid Biopsy Market
6 COVID-19 Impact Assessment
6.1 Impact of COVID-19 on Liquid Biopsy Market
6.2 Quarterly Covid Impact Analysis by Region (2020)
7 Porter’s Five Forces Analysis
8 Outlook for macroeconomic indicators
8.1 GDP Growth Rate per Capita (% per annum)
8.2 Global healthcare spending in 2020, by region (% of total)
8.3 Current Medical Expenses
8.4 Pharmaceutical expenditure/person
8.5 Incidence of cancer
9 Global Liquid Biopsy Market
9.1 Impact Analysis of Macroeconomic Factors on Liquid Biopsy Market
9.2 Snapshot
9.3 Global Liquid Biopsy Market: Market Valuation
9.4 Market overview
10. Global Liquid Biopsy Market Trends and Forecast Analysis, 2018-2028, By Biomarker Type
10.1 Global Liquid Biopsy Market Trends and Forecast Analysis, Biomarker Types: Snapshot
10.2 Circulating tumor cells (CTC)
10.3 Circulating tumor DNA (ctDNA)
10.4 Extracellular vesicles
10.5 Other biomarkers
11. Global Liquid Biopsy Market Trends and Forecast Analysis, 2018-2028, By Indication
11.1 Global Liquid Biopsy Market Trends and Forecast Analysis, By Indication: Snapshot
11.2 Cancer
11.3 Prenatal screening
11.4 Miscellaneous
12. Global Liquid Biopsy Market Trends and Forecast Analysis, 2018-2028, By Product
12.1 Global Liquid Biopsy Market Trends and Forecast Analysis, By Product: Snapshot
12.2 Assay Kit
12.3 Equipment and devices
12.4 Services
13. Global Liquid Biopsy Market Trends and Forecast Analysis, 2018-2028, By Region
13.1 Survey Area
For more information on this report, please visit https://www.researchandmarkets.com/r/kg9k3x-liquid?w=12.
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. It provides up-to-date data on international and regional markets, key industries, top companies, new products and latest trends.
-
Global Liquid Biopsy Market
